Ford Should Give Back Its Quality Award, Analysts Say
Ford faces renewed scrutiny as recalls mount and U.S. sales soften, fueling a debate over whether ford should give ba...
Which Sp 500 Fund Is Better For Iras 2024
Compare Which Sp 500 Fund Is Better For Iras 2024 to assess fund strengths for IRAs. Focus on fees, performance, and diversification.
24,720 articles
CRWV vs QQQ: CoreWeave Explosive AI Bet or Safety Net
CoreWeave delivers a record bookings quarter but sinks on concentration fears, while QQQ holds steady amid AI volatil...
How a Million Dividend Portfolio Generate $100K Annually
Investors eye a disciplined, risk-aware blueprint for a million dividend portfolio generate about $100,000 annually, ...
The $293 Billion Fight Over Satoshi's Bitcoin Intensifies
A landmark civil suit over ownership of long-dormant Bitcoin addresses has narrowed, with key defendants exiting as o...
Prediction: Could Costco Stock Reach $2,000 by 2030?
Costco stock sits in the mid-700s as of July 2026. Analysts weigh whether a $2,000 target by 2030 is plausible, consi...
Why Household Staff Earn $300,000 in Wealthy Households
Ultra-wealth households are paying premium to private staff amid a tightening labor market, with some packages includ...
Michael Dell Celebrates America’s 250th with Dream Seed Gift
A bold Independence Day plan envisions millions of U.S. kids gaining a financial stake in the economy, blending phila...
Brooklyn Rehab Owner Wanted: Inside a Fraud Case Story
A Brooklyn rehab clinic case has public officials chasing a suspected scam spanning years. This article breaks down w...
Real Case Buying Johnson: A Close Look at JNJ in July
As Johnson & Johnson prepares July earnings, investors weigh the real case buying johnson thesis driven by durable in...
AI Likely to Strengthen Large Mortgage Lenders, KBW Says
A July 12 KBW report argues artificial intelligence will fortify the industry’s largest lenders rather than upend the...
What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Late AppLovin After 1,428% Run: Is It Still a Buy?
AppLovin rode a massive multi-year rally, but a pivot to pure-play ad tech and a softening macro beat have investors ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status